دورية أكاديمية
131P Safety and clinical efficacy of roginolisib (IOA-244): The first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ)
| العنوان: | 131P Safety and clinical efficacy of roginolisib (IOA-244): The first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) |
|---|---|
| المؤلفون: | Di Giacomo, A.M., Simonelli, M., Santangelo, F., Amato, G., Simonetti, E., Graham, J., Lahn, M., Di Conza, G., Hammett, T., Zorrilla, R., Kaur, P., Ziyang, T., Lakshmikanth, T., Brodin, P., Occhipinti, M., Carlo-Stella, C., Santoro, A., Spiliopoulou, P., Evans, T.R.J., Maio, M. |
| المصدر: | Immuno-Oncology and Technology ; volume 20, page 100603 ; ISSN 2590-0188 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Immunology and Allergy |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.iotech.2023.100603 |
| الإتاحة: | https://doi.org/10.1016/j.iotech.2023.100603Test https://api.elsevier.com/content/article/PII:S2590018823002666?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2590018823002666?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.607DEF02 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.iotech.2023.100603 |
|---|